期刊文献+

二次玻璃体腔注射曲安奈德治疗糖尿病性黄斑水肿 被引量:18

Treatment of diabetic macular edema by dual intravitreal injections of triamcinolone
下载PDF
导出
摘要 目的:探讨二次玻璃体腔注射曲安奈德治疗糖尿病黄斑水肿的疗效。方法:治疗组在首次玻璃体腔注射曲安奈德平均3.6mo后二次注射。对照组玻璃体腔只注射一次曲安奈德,两组注射剂量均为20mg,并辅助维生素类、烟酸酯和达纳康、弥可保等口服。在指定观察期内进行疗效对比。结果:治疗组视力平均提高0.32±0.19,对照组视力平均提高0.17±0.14,两者存在显著性差异(t=3.251,P<0.05)。结论:糖尿病黄斑水肿经过二次玻璃体腔注射曲安奈德后能够产生良好的疗效。 AIM: To explore the effect of dual intravitreal injections of triamcinolone on diabetic macular edema(DME). METHODS: The treated group was given the secondary intravitreal injection of triamcinolone 3.6mo after the primary injection. The control group received only one injection.The dose of triamcinolone injection in both groups was 20mg. The patients in both group were given the same dose of vitamins, niconacid,Tanakan and Methycobal. The therapeutic outcome was compared between the two groups within the observed time. RESULTS: The visual acuity in treated group was increased 0.32±0.19 line averagely, compared with 0.17±0.14 in control group. Significant difference was found between the two groups (t=3.251,P〈0.05). CONCLUSION: Dual intravitreal injection of triamcinolone is effective on treatment of DEM.
出处 《国际眼科杂志》 CAS 2005年第6期1207-1210,共4页 International Eye Science
关键词 糖尿病性黄斑水肿(DME) 激素 曲安奈德 diabetic macular edema (DME) hormone triamcinolone
  • 相关文献

参考文献13

  • 1陆小明,梁社生,谭国萍.糖尿病性视网膜病变170例随访分析[J].国际眼科杂志,2005,5(3):578-580. 被引量:5
  • 2Jonas JB.Intraocular availability of triamcinolone acetonide after intravitreal injection.Am J Ophthalmol,2004;137:560-562
  • 3张美霞,杨兰芬,罗成仁,严密,孟丹,沈齐,杜彩凤.糖尿病视网膜病变黄斑水肿的临床分析[J].中华眼底病杂志,2003,19(2):83-86. 被引量:26
  • 4惠延年,王琳.糖尿病视网膜病变和黄斑水肿的国际临床分类法[J].国际眼科杂志,2004,4(1):56-59. 被引量:95
  • 5Antcliff RJ,Spalton DJ,Stanford MR,Ali A.Intravitreal triamcinolone for uveitic cystoid macular edema:an optical coherence tomography study.Ophthalmology,2001; 108:765-772
  • 6Beer PM,Bakri S J,Singh R J,Liu W,Peters GB,Miller M.Intraocular concentration and pharmacokinetics of tramcinolone acetonide after a single intravitreal injection.Ophthalmology,2003;110:681-686
  • 7Jonas JB,Kreissig I,Degenring R.Intraocular pressure after intravitreal injection of triamcinolone acetonide.Br J Ophthalmol,2003;87:24-27
  • 8Jonas JB,Kreissig I,Sofker A,Robert F.Intravitreal injection of triamcinolone acetonide for diffuse diabetic macular edema.Arch Ophthalmol,2003;121:57-61
  • 9Martidis A,Duker JS,Greenberg PB,Carmen A.Intravitreal triamcinolone for refractory diabetic macular edema.Ophthalmology,2002;109:920-927
  • 10Degenring RF,Kreissig I.Fluorescein Angiography after Intravitreal Injection of Triamcinolone Acetonide as Treatment of Diffuse Diabetic Macular Edema.Br J Ophthalmol,2003 ;87 (2):89 ~ 92

二级参考文献41

  • 1Klein R, Klein BE, Moss SE. The Wisconsin epidemiological study of diabetic retinopathy. Ⅸ. Four-year incidence and progression of diabetic retinopathy when age of diagnosis is less than 30 years. Arch Ophthalmol,1989;107:237-243
  • 2Chew EY. A simplified diabetic retinopathy scale. Ophthalmology, 2003;110(9): 1675-7676
  • 3Sato Y, Lee Z. The subclassification and long-term prognosis of proliferative diabetic retinopathy.Jpn J Ophthalmol, 2002;46(3):323-329.
  • 4Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalomlogy, 1991;98:766-785.
  • 5Wilkinson CP, Ferris FL Ⅲ, Klein RE, Lee PP, Agardh CD, Davis M.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalomlogy, 2003; 110(9): 1677-1682
  • 6Antcliff RJ,Spalton DJ,Stanford MR,et al. Intravitreal triamcinolone for uveitic cystoid macular edema:an optical coherence tomography study. Ophthalmology,2001,108: 765-772.
  • 7LashayAR, Rahimi A,Chams H,et al. Evaluation of the effect of acetzolamide on cystoid macular edema in patients with Behcet′s disease. Eye,2003,17:762-766.
  • 8Kobayashi H,Kobayashi K,Okinami S. Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal. Am J Ophthalmol, 2003,136:244-251.
  • 9Campochiaro PA,The C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci, 2004,45: 922-931.
  • 10Danis RP,Bingaman DP,Yang Y,et al. Inhibition of preretinal and optic nerve head neovascularization in pig by intravitreal triamcinolone acetonide. Ophthalmol,1996,103: 2099-2104.

共引文献145

同被引文献150

引证文献18

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部